Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRASS study: Cannabidiol for anxiety in glioma patients
2020-004294-48Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cannabidiol in primary brain cancer and anxiety disorder (2 arms), sponsored by Amsterdam University Medical Center. Started Jul 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
primary brain canceranxiety disorder
Beyond the preview
Go deeper on 2020-004294-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004294-48.